Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Q4 2024 Earnings Call Transcript October 15, 2024 8:30 AM ET Company Participants Tiffany Kanaga - VP of Global IR Tim Wentworth - CEO Manmohan Mahajan - Global CFO Mary Langowski - President, US Healthcare Conference Call Participants Lisa Gill - JPMorgan Ann Hynes - Mizuho Group George Hill - Deutsche Bank Charles Rhyee - TD Securities Eric Percher - Nephron Research Kevin Caliendo - UBS Elizabeth Anderson - Evercore ISI Michael Cherny - Leerink Partners Stephan ...

Walgreens Boots Alliance, Inc. (WBA) delivered adjusted earnings per share (EPS) of 39 cents in the fourth quarter of fiscal 2024, down 41.8% from the year-ago quarter’s figure (down 40.8% at constant exchange rate or CER). However, the figure topped the Zacks Consensus Estimate by 8.3%.GAAP loss per share for the fourth quarter was $3.48, wider than the year-ago quarter’s 21 cents loss.For the full year, adjusted EPS was $2.88, a 27.6% decline from fiscal 2023 (down 27.9% at CER). This exceeded the Zacks C ...

Walgreens Boots Alliance is undertaking a transformation focused on its retail pharmacy business in response to persistent challenges in the consumer market and pharmacy sector. As part of this strategy, the company plans to close approximately 1,200 underperforming stores in the next three years to streamline operations and increase profitability.A challenging consumer spending environment served as a main theme Tuesday (Oct. 15) during the company’s fourth-quarter earnings call.“The consumer may get stron ...

Investors are applauding the pharmacy retailer's plan to close many of its unprofitable stores.Shares of Walgreens Boots Alliance (WBA 11.72%) were skyrocketing 14% higher as of 11:14 a.m. ET on Tuesday. The huge gain came after the pharmacy retailer announced its fiscal 2024 fourth-quarter results earlier in the morning.Walgreens reported sales of $37.5 billion for the period ended Aug. 31, up 6% year over year. The average analysts' estimate was for Q4 revenue of $35.75 billion, according to LSEG.The comp ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

For the quarter ended August 2024, Walgreens Boots Alliance (WBA) reported revenue of $37.55 billion, up 6% over the same period last year. EPS came in at $0.39, compared to $0.67 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $35.74 billion, representing a surprise of +5.07%. The company delivered an EPS surprise of +8.33%, with the consensus EPS estimate being $0.36.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wa ...

KEY TAKEAWAYSWalgreens Boots Alliance said Tuesday that it is shutting around 1,200 stores over the next three years, as the drugstore chain moves to turn around its troubled U.S. business.The chain said it would shut 500 stores in fiscal 2025, and that the closures would be "immediately accretive" to its adjusted EPS and free cash flow.Walgreens also reported fourth-quarter revenue and adjusted EPS that beat Wall Street estimates.Shares of the company are rising more than 3% in premarket trading. Walgreens ...

Financial Performance - Fiscal Year 2024 - Sales increased by 6.2% to $147.658 billion[13] - Adjusted operating income decreased by 32.2% to $2.624 billion[13] - GAAP net loss was $8.636 billion, compared to a net loss of $3.080 billion in FY23[13] - Adjusted EPS decreased by 27.6% to $2.88[13] Financial Performance - Fourth Quarter 2024 - Sales increased by 6.0% to $37.547 billion[11] - Adjusted operating income decreased by 37.9% to $424 million[11] - GAAP net loss was $3.005 billion, compared to a net loss of $180 million in 4Q23[11] - Adjusted EPS decreased by 41.0% to $0.39[11] U.S. Retail Pharmacy - Fourth Quarter 2024 - Sales increased by 6.5% to $29.470 billion[14] - Adjusted operating income decreased by 60.4% to $220 million[14] - Comparable pharmacy sales increased by 11.7% primarily due to brand inflation and mix impacts[15] - Comparable scripts increased by 2.5%, and excluding immunizations, comparable scripts increased by 2.6%[15] U.S. Retail - Fourth Quarter 2024 - Total retail sales decreased by 3.5%[17] - Comparable retail sales decreased by 1.7%, reflecting a challenging retail environment and continued channel shift[17] International - Fourth Quarter 2024 - Sales increased by 3.7% to $5.971 billion, driven by Germany wholesale and Boots UK[19] - Adjusted operating income decreased by 10.6% to $231 million, mainly due to lapping real estate gains in the year-ago period[19] U.S. Healthcare - Fourth Quarter 2024 - Sales were $2.1 billion, led by VillageMD ($1.5 billion), CareCentrix ($0.4 billion), and Shields ($0.2 billion)[22] - Sales growth was +7%, led by VillageMD +7% and Shields +28%[22] - Adjusted EBITDA improved by $94 million compared to 4Q23, driven by cost savings at VillageMD and growth at Shields[22] FY25 Guidance - Adjusted EPS is expected to be between $1.40 and $1.80[27] - The company expects to close approximately 1,200 locations over the next three years, with approximately 500 in FY25[29] - The company expects sales between $147.0 and $151.0 billion[30]

Walgreens Boots Alliance (WBA) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.67 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 8.33%. A quarter ago, it was expected that this largest U.S. drugstore chain would post earnings of $0.67 per share when it actually produced earnings of $0.63, delivering a surprise of -5.97%.Over the last ...

Walgreens plans to close at least 1,200 stores over the next three years as the pharmacy giant seeks to reduce costs and turn around operations under a new leader.  One of the largest drugstore chains in the country, Walgreens said it was targeting 900 to 1,000 stores primarily across the U.S. by the end of fiscal year 2027, which is part of the company's "multi-year footprint optimization program." About 500 stores are slated to close as early as fiscal year 2025.WALGREENS TO PAY $106.8M OVER CLAIMS IT BIL ...